Dr Caroline L Gibbes, | |
2601 Laurel St Ste 110, Cola, SC 29204 | |
(803) 256-7494 | |
(803) 799-0746 |
Full Name | Dr Caroline L Gibbes |
---|---|
Gender | Female |
Speciality | Ophthalmology |
Location | 2601 Laurel St Ste 110, Cola, South Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194762831 | NPI | - | NPPES |
092054 PC1477 | Medicaid | SC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 9205 (South Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Caroline L Gibbes, 2601 Laurel St Ste 110, Columbia, SC 29204 Ph: (803) 256-7494 | Dr Caroline L Gibbes, 2601 Laurel St Ste 110, Cola, SC 29204 Ph: (803) 256-7494 |
News Archive
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced it will offer clinical laboratory testing using the PD-L1 IHC 28-8 pharmDx qualitative test from Dako, an Agilent Technologies company.
A disposable cup – favoured by many of the high street's well known coffee shops – is the inspiration behind a new and scientifically reviewed device for the safe and prompt treatment of school age children suffering acute asthma, which often presents as an emergency situation.
InDepth Pharmaceuticals, founded by Deepak Nihalani, Ph.D., the SmartState Endowed Chair in Renal Disease Biomarkers at the Medical University of South Carolina, has taken a vital step toward commercializing an innovative diagnostic technique that could better predict kidney transplant success in patients with focal segmental glomerulosclerosis (FSGS), a kidney disease that often leads to end-stage renal failure.
Cancer Research UK scientists have shed new light on the vital role that a protein plays in protecting our DNA, reveals a study published in Nature Structural and Molecular Biology today.
Quintiles, the world's leading biopharmaceutical services company, and London Genetics, an expert in the use of pharmacogenetics in drug discovery and development, today announced a strategic alliance to offer the biopharmaceutical industry innovative pharmacogenetics solutions to advance personalized medicine. Financial terms were not disclosed.
› Verified 4 days ago